Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 15, Issue 22
|
pp. 13265–13286
Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients
Back to article
Figure 2
(2 of 7)
−
100%
+
Figure 2.
KLRB1 in relation to clinical features in BC.
(
A
–
D
) T stage; (
E
) Pathological stage; (
F
) Age; (
G
) Her2 status; (
H
–
J
) The better prognosis related the KLRB1 overexpression.